Literature DB >> 11101610

Comparison of human immunodeficiency virus type 1 RNA sequence heterogeneity in cerebrospinal fluid and plasma.

Y W Tang1, J T Huong, R M Lloyd, P Spearman, D W Haas.   

Abstract

The source of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid (CSF) during HIV-1 infection is uncertain. The sequence heterogeneity of HIV-1 RNA in simultaneous CSF and plasma samples was characterized for five patients at the baseline and during the first week of antiretroviral therapy by two commercial genotyping methodologies. In individual subjects, the sequences in CSF samples differed significantly from those in plasma. In contrast, the viral sequences in CSF at the baseline did not differ from the sequences in CSF during treatment. Similarly, viral sequences in plasma did not vary over this interval. This study provides evidence that HIV-1 RNA in CSF and plasma arise from distinct compartments.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11101610      PMCID: PMC87651     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine.

Authors:  M Gisslén; G Norkrans; B Svennerholm; L Hagberg
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

2.  Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir.

Authors:  G Pialoux; S Fournier; A Moulignier; J D Poveda; F Clavel; B Dupont
Journal:  AIDS       Date:  1997-08       Impact factor: 4.177

3.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors:  F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

4.  Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.

Authors:  J C McArthur; D R McClernon; M F Cronin; T E Nance-Sproson; A J Saah; M St Clair; E R Lanier
Journal:  Ann Neurol       Date:  1997-11       Impact factor: 10.422

5.  Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis.

Authors:  P Cinque; L Vago; D Ceresa; F Mainini; M R Terreni; A Vagani; W Torri; S Bossolasco; A Lazzarin
Journal:  AIDS       Date:  1998-03-05       Impact factor: 4.177

6.  HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement.

Authors:  J E Bell; R P Brettle; A Chiswick; P Simmonds
Journal:  Brain       Date:  1998-11       Impact factor: 13.501

7.  Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

Authors:  A Mocroft; S Vella; T L Benfield; A Chiesi; V Miller; P Gargalianos; A d'Arminio Monforte; I Yust; J N Bruun; A N Phillips; J D Lundgren
Journal:  Lancet       Date:  1998-11-28       Impact factor: 79.321

Review 8.  Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

Authors:  M S Hirsch; B Conway; R T D'Aquila; V A Johnson; F Brun-Vézinet; B Clotet; L M Demeter; S M Hammer; D M Jacobsen; D R Kuritzkes; C Loveday; J W Mellors; S Vella; D D Richman
Journal:  JAMA       Date:  1998-06-24       Impact factor: 56.272

9.  Evaluation of the Nuclisens HIV-1 QT assay for quantitation of human immunodeficiency virus type 1 RNA levels in plasma.

Authors:  M Segondy; T D Ly; M Lapeyre; B Montes
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

10.  Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy.

Authors:  H Albrecht; C Hoffmann; O Degen; A Stoehr; A Plettenberg; T Mertenskötter; C Eggers; H J Stellbrink
Journal:  AIDS       Date:  1998-07-09       Impact factor: 4.177

View more
  11 in total

1.  Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cells.

Authors:  Patrick R Harrington; David W Haas; Kimberly Ritola; Ronald Swanstrom
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia.

Authors:  Kimberly Ritola; Kevin Robertson; Susan A Fiscus; Colin Hall; Ronald Swanstrom
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 3.  Compartmentalization, Viral Evolution, and Viral Latency of HIV in the CNS.

Authors:  Maria M Bednar; Christa Buckheit Sturdevant; Lauren A Tompkins; Kathryn Twigg Arrildt; Elena Dukhovlinova; Laura P Kincer; Ronald Swanstrom
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

4.  Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients.

Authors:  Caroline Solas; Alain Lafeuillade; Philippe Halfon; Stéphane Chadapaud; Gilles Hittinger; Bruno Lacarelle
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

5.  Enhancement of human immunodeficiency virus (HIV)-specific CD8+ T cells in cerebrospinal fluid compared to those in blood among antiretroviral therapy-naive HIV-positive subjects.

Authors:  Shanmugalakshmi Sadagopal; Shelly L Lorey; Louise Barnett; Rebecca Basham; Laurie Lebo; Husamettin Erdem; Kirsten Haman; Malcolm Avison; Kevin Waddell; David W Haas; Spyros A Kalams
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

6.  Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course.

Authors:  Patrick R Harrington; Gretja Schnell; Scott L Letendre; Kimberly Ritola; Kevin Robertson; Colin Hall; Christina L Burch; Cassandra B Jabara; Dominic T Moore; Ronald J Ellis; Richard W Price; Ronald Swanstrom
Journal:  AIDS       Date:  2009-05-15       Impact factor: 4.177

Review 7.  Sequence heterogeneity and viral dynamics in cerebrospinal fluid and plasma during antiretroviral therapy.

Authors:  David W Haas
Journal:  J Neurovirol       Date:  2004       Impact factor: 2.643

8.  Long-term virological effect of highly active antiretroviral therapy on cerebrospinal fluid and relationship with genotypic resistance.

Authors:  Arabella Bestetti; Silvia Presi; Chiara Pierotti; Simona Bossolasco; Serena Sala; Sara Racca; Paola Carrera; Adriano Lazzarin; Paola Cinque
Journal:  J Neurovirol       Date:  2004       Impact factor: 2.643

Review 9.  Past, present and future molecular diagnosis and characterization of human immunodeficiency virus infections.

Authors:  Yi-Wei Tang; Chin-Yih Ou
Journal:  Emerg Microbes Infect       Date:  2012-08-22       Impact factor: 7.163

10.  Modelling the HIV persistence through the network of lymphocyte recirculation in vivo.

Authors:  Ying Huang; Chen Zhang; Jianhong Wu; Jie Lou
Journal:  Infect Dis Model       Date:  2017-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.